S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
SWOG Cancer Research Network
SWOG Cancer Research Network
Ohio State University Comprehensive Cancer Center
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
NSABP Foundation Inc
Fox Chase Cancer Center
SillaJen, Inc.
Alliance for Clinical Trials in Oncology
Merck Sharp & Dohme LLC
Radiation Therapy Oncology Group
Northwestern University
National Cancer Institute (NCI)
Amgen
Generic Devices Consulting, Inc.
Washington University School of Medicine
OHSU Knight Cancer Institute
University of Miami
Alliance for Clinical Trials in Oncology
H. Lee Moffitt Cancer Center and Research Institute
City of Hope Medical Center
University of Pittsburgh
Hoosier Cancer Research Network
Hoffmann-La Roche
Amgen
National Cancer Institute (NCI)
National Cancer Institute (NCI)